Shots:

• AstraZeneca collaborates with the Mexican and Argentinean governments to initially produce 150M doses of the vaccine and eventually make at least 400M for distribution throughout the region
• The price for the vaccine is not final but it is expected not to exceed $4/ dose. The vaccine will initially supply to all Latin American countries except Brazil
• The clinical trial conducted in the US- South Africa- England- and Brazil is expected to be completed in Nov or Dec’2020- after which the company would seek approvals. If approved- AstraZeneca will transfer technology to Argentina’s INSUD Group and Mexico’s Laboratorios Liomont at the end of the year and begin manufacturing in Q1’21

­ Ref: Reuters | Image: Bloomberg